• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在巴雷特食管患者中,病理学家使用大面积经上皮采样及计算机辅助分析的观察者间一致性

Inter-Observer Agreement among Pathologists Using Wide-Area Transepithelial Sampling With Computer-Assisted Analysis in Patients With Barrett's Esophagus.

作者信息

Vennalaganti Prashanth R, Naag Kanakadandi Vijay, Gross Seth A, Parasa Sravanthi, Wang Kenneth K, Gupta Neil, Sharma Prateek

机构信息

Department of Gastroenterology, Kansas City Veterans Affairs Medical Center, Kansas City, Missouri, USA.

Department of Gastroenterology, University of Kansas Medical Center, Kansas City, Kansas, USA.

出版信息

Am J Gastroenterol. 2015 Sep;110(9):1257-60. doi: 10.1038/ajg.2015.116. Epub 2015 Apr 28.

DOI:10.1038/ajg.2015.116
PMID:25916227
Abstract

OBJECTIVES

The histopathological diagnosis of Barrett's esophagus (BE)-associated dysplasia has poor inter-observer agreement. The wide-area transepithelial sampling (WATS) procedure uses a minimally invasive brush biopsy technique for acquiring wide-area sampling of BE tissue followed by computer-assisted analysis. In this study, our aim was to assess inter-observer agreement among pathologists in the diagnosis of Barrett's-associated dysplasia using the WATS computer-assisted analysis technique.

METHODS

WATS slides with varying degrees of BE dysplasia were randomly selected and distributed to four pathologists. Each pathologist graded the slides as nondysplastic, low-grade dysplasia (LGD), or high-grade dysplasia/esophageal adenocarcinoma (HGD/EAC) and completed a standardized case report form (CRF) for each slide.

RESULTS

In all, 149 BE slides were evaluated in a blinded manner by 4 pathologists. The slides included the following: no dysplasia (n=109), LGD, and HGD/EAC (n=40). The overall mean kappa value for all 3 diagnoses for the 4 observers was calculated at 0.86 (95% confidence interval (CI) 0.75-0.97). The kappa values (95% CI) for HGD/EAC, IND/LGD, and no dysplasia were 0.95 (0.88-0.99), 0.74 (0.61-0.85), and 0.88 (0.81-0.94), respectively.

CONCLUSIONS

The diagnosis of BE and associated dysplasia using the WATS technique has very high inter-observer agreement. This appears to be significantly higher as compared with previously published data using standard histopathology.

摘要

目的

巴雷特食管(BE)相关发育异常的组织病理学诊断在观察者之间的一致性较差。广域经上皮采样(WATS)程序使用微创刷检活检技术获取BE组织的广域样本,随后进行计算机辅助分析。在本研究中,我们的目的是评估病理学家使用WATS计算机辅助分析技术诊断巴雷特相关发育异常时观察者之间的一致性。

方法

随机选择具有不同程度BE发育异常的WATS载玻片并分发给四位病理学家。每位病理学家将载玻片分级为无发育异常、低级别发育异常(LGD)或高级别发育异常/食管腺癌(HGD/EAC),并为每张载玻片填写标准化病例报告表(CRF)。

结果

总共4位病理学家以盲法评估了149张BE载玻片。这些载玻片包括:无发育异常(n = 109)、LGD和HGD/EAC(n = 40)。计算出4位观察者对所有3种诊断的总体平均kappa值为0.86(95%置信区间(CI)0.75 - 0.97)。HGD/EAC、IND/LGD和无发育异常的kappa值(95% CI)分别为0.95(0.88 - 0.99)、0.74(0.61 - 0.85)和0.88(0.81 - 0.94)。

结论

使用WATS技术诊断BE及相关发育异常具有非常高的观察者间一致性。与先前发表的使用标准组织病理学的数据相比,这一一致性似乎显著更高。

相似文献

1
Inter-Observer Agreement among Pathologists Using Wide-Area Transepithelial Sampling With Computer-Assisted Analysis in Patients With Barrett's Esophagus.在巴雷特食管患者中,病理学家使用大面积经上皮采样及计算机辅助分析的观察者间一致性
Am J Gastroenterol. 2015 Sep;110(9):1257-60. doi: 10.1038/ajg.2015.116. Epub 2015 Apr 28.
2
Discordance Among Pathologists in the United States and Europe in Diagnosis of Low-Grade Dysplasia for Patients With Barrett's Esophagus.美国和欧洲病理学家在诊断 Barrett 食管低级别异型增生患者中的分歧。
Gastroenterology. 2017 Feb;152(3):564-570.e4. doi: 10.1053/j.gastro.2016.10.041. Epub 2016 Nov 3.
3
The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.巴雷特食管低度发育异常的诊断及其对疾病进展的影响。
Am J Gastroenterol. 2000 Dec;95(12):3383-7. doi: 10.1111/j.1572-0241.2000.03348.x.
4
Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.巴雷特食管患者低级别上皮内瘤变进展的危险因素。
Gastroenterology. 2011 Oct;141(4):1179-86, 1186.e1. doi: 10.1053/j.gastro.2011.06.055. Epub 2011 Jun 30.
5
Increased detection of Barrett's esophagus-associated neoplasia using wide-area trans-epithelial sampling: a multicenter, prospective, randomized trial.使用广域跨上皮采样提高 Barrett 食管相关肿瘤的检出率:一项多中心、前瞻性、随机试验。
Gastrointest Endosc. 2018 Feb;87(2):348-355. doi: 10.1016/j.gie.2017.07.039. Epub 2017 Jul 27.
6
Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists.由两名或更多病理学家诊断的巴雷特食管患者从低度发育异常进展为恶性肿瘤。
World J Gastroenterol. 2016 Oct 21;22(39):8831-8843. doi: 10.3748/wjg.v22.i39.8831.
7
SAGES TAVAC safety and efficacy analysis WATS (CDx Diagnostics, Suffern, NY).SAGES TAVAC 安全与疗效分析 WATS(CDx 诊断公司,萨芬,纽约)。
Surg Endosc. 2020 Sep;34(9):3743-3747. doi: 10.1007/s00464-020-07503-w. Epub 2020 Mar 11.
8
Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.巴雷特食管伴低级别上皮内瘤变或异型增生不明确患者的风险分层。
Clin Gastroenterol Hepatol. 2015 Mar;13(3):459-465.e1. doi: 10.1016/j.cgh.2014.07.049. Epub 2014 Aug 4.
9
Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.诊断为不典型增生的巴雷特食管的肿瘤进展风险:一项全国性队列研究。
Endoscopy. 2015 May;47(5):409-14. doi: 10.1055/s-0034-1391091. Epub 2014 Dec 18.
10
WATS 3D : An Interobserver Study of Barrett's Esophagus-Associated Dysplasia Among Gastrointestinal Pathologists.WATS 3D:胃肠病理学家间 Barrett 食管相关异型增生的观察性研究。
Clin Transl Gastroenterol. 2024 Feb 1;15(2):e00661. doi: 10.14309/ctg.0000000000000661.

引用本文的文献

1
Latest Advances in Endoscopic Detection of Oesophageal and Gastric Neoplasia.食管和胃肿瘤内镜检测的最新进展
Diagnostics (Basel). 2024 Jan 30;14(3):301. doi: 10.3390/diagnostics14030301.
2
Molecular Biology and Clinical Management of Esophageal Adenocarcinoma.食管腺癌的分子生物学与临床管理
Cancers (Basel). 2023 Nov 14;15(22):5410. doi: 10.3390/cancers15225410.
3
Utility of ancillary studies in the diagnosis and risk assessment of Barrett's esophagus and dysplasia.辅助研究在 Barrett 食管和异型增生的诊断和风险评估中的作用。

本文引用的文献

1
Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study.食管腺癌和巴雷特食管的先前诊断:一项基于人群的研究。
Gut. 2015 Jan;64(1):20-5. doi: 10.1136/gutjnl-2013-305506. Epub 2014 Apr 3.
2
Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus.内镜和非内镜细胞刷筛查 Barrett 食管的健康获益和成本效益。
Gastroenterology. 2013 Jan;144(1):62-73.e6. doi: 10.1053/j.gastro.2012.09.060. Epub 2012 Oct 3.
3
Screening and surveillance for Barrett's esophagus: current issues and future directions.
Mod Pathol. 2022 Aug;35(8):1000-1012. doi: 10.1038/s41379-022-01056-0. Epub 2022 Mar 8.
4
A Rapid Cytological Screening as pre-Endoscopy Screening for Early Esophageal Squamous Cell Lesions: A Prospective Pilot Study from a Chinese Academic Center.快速细胞学筛查作为内镜检查前对早期食管鳞状细胞病变的筛查:来自中国学术中心的前瞻性试点研究。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338211066200. doi: 10.1177/15330338211066200.
5
Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression.巴雷特食管:肿瘤进展的病理形态和分子遗传学关键。
Cancer Med. 2022 Jan;11(2):447-478. doi: 10.1002/cam4.4447. Epub 2021 Dec 6.
6
Wide-area transepithelial sampling for dysplasia detection in Barrett's esophagus: a systematic review and meta-analysis.大面积跨上皮采样在 Barrett 食管异型增生检测中的应用:系统评价和荟萃分析。
Gastrointest Endosc. 2022 Jan;95(1):51-59.e7. doi: 10.1016/j.gie.2021.09.015. Epub 2021 Sep 17.
7
WATS versus forceps biopsy in screening for Barrett's esophagus: experience in community endoscopy centers.在巴雷特食管筛查中,水囊辅助内镜黏膜切除术(WATS)与钳取活检的比较:社区内镜中心的经验
Ann Gastroenterol. 2021;34(2):164-168. doi: 10.20524/aog.2020.0564. Epub 2020 Dec 7.
8
The Impact of Artificial Intelligence in the Endoscopic Assessment of Premalignant and Malignant Esophageal Lesions: Present and Future.人工智能在食管早癌及癌前病变内镜评估中的作用:现状与未来。
Medicina (Kaunas). 2020 Jul 21;56(7):364. doi: 10.3390/medicina56070364.
9
Wide Area Transepithelial Sampling with Computer-Assisted Analysis (WATS) Is Cost-Effective in Barrett's Esophagus Screening.计算机辅助分析广域上皮细胞采样(WATS)在 Barrett 食管筛查中具有成本效益。
Dig Dis Sci. 2021 May;66(5):1572-1579. doi: 10.1007/s10620-020-06412-1. Epub 2020 Jun 23.
10
Volumetric laser endomicroscopy in Barrett's esophagus: ready for primetime.巴雷特食管的容积激光内镜检查:准备好进入黄金时代。
Transl Gastroenterol Hepatol. 2020 Apr 5;5:27. doi: 10.21037/tgh.2019.11.16. eCollection 2020.
巴雷特食管的筛查和监测:当前问题与未来方向。
Curr Opin Gastroenterol. 2012 Jul;28(4):377-81. doi: 10.1097/MOG.0b013e328353d58e.
4
Cytosponge for Barrett's esophagus screening: when smart science matches simplicity.用于巴雷特食管筛查的细胞海绵:当智能科学与简易性相结合时。
Gastroenterology. 2011 Aug;141(2):766-8; discussion 768. doi: 10.1053/j.gastro.2011.06.012. Epub 2011 Jun 23.
5
Developing a nonendoscopic screening test for Barrett's esophagus.开发一种非内镜筛查 Barrett 食管的方法。
Biomark Med. 2011 Jun;5(3):397-404. doi: 10.2217/bmm.11.40.
6
American Gastroenterological Association medical position statement on the management of Barrett's esophagus.美国胃肠病学会关于巴雷特食管管理的医学立场声明。
Gastroenterology. 2011 Mar;140(3):1084-91. doi: 10.1053/j.gastro.2011.01.030.
7
Computer-assisted analysis of abrasive transepithelial brush biopsies increases the effectiveness of esophageal screening: a multicenter prospective clinical trial by the EndoCDx Collaborative Group.计算机辅助分析磨蚀性跨上皮刷活检可提高食管筛查的效果:EndoCDx 协作组的一项多中心前瞻性临床试验。
Dig Dis Sci. 2011 Mar;56(3):767-72. doi: 10.1007/s10620-010-1497-6. Epub 2010 Dec 4.
8
Diagnostic challenges in the pathologic evaluation of Barrett esophagus.巴雷特食管病理评估中的诊断挑战。
Arch Pathol Lab Med. 2010 Nov;134(11):1589-600. doi: 10.5858/2009-0547-RAR1.1.
9
Computer-assisted brush-biopsy analysis for the detection of dysplasia in a high-risk Barrett's esophagus surveillance population.计算机辅助毛刷活检分析在高危 Barrett 食管监测人群中用于检测异型增生。
Dig Dis Sci. 2011 Mar;56(3):761-6. doi: 10.1007/s10620-010-1459-z. Epub 2010 Oct 27.
10
Controversies in the diagnosis of Barrett esophagus and Barrett-related dysplasia: one pathologist's perspective.巴雷特食管和巴雷特相关异型增生诊断中的争议:一位病理学家的观点。
Arch Pathol Lab Med. 2010 Oct;134(10):1479-84. doi: 10.5858/2010-0249-RA.1.